Analysis of Awareness and Attitudes of the Adult Population Towards Urogenital System Diseases
DOI:
https://doi.org/10.32782/2786-7684/2025-1-19Keywords:
urogenital system diseases, awareness, risk factors, bladder cancer, sexually transmitted infections, prevention, healthy lifestyle, harmful habits, medical check-upsAbstract
Introduction. Diseases of the genitourinary system are a significant medical and social issue, as they affect the quality of life, work capacity, and reproductive health of the population. They may go unnoticed due to a lack of awareness and insufficient preventive measures among the population, which is especially relevant for conditions such as sexually transmitted infections, injuries, polyps, bladder cancer, and chronic kidney diseases. Research Aim. The aim of this study is to assess the level of awareness among men and women regarding urogenital system diseases, particularly bladder cancer and sexually transmitted infections, as well as their attitudes toward a healthy lifestyle, frequency of doctor visits, and risks associated with harmful habits and infections. Materials and Methods. The study employs a quantitative approach using sociological surveys as the main data collection method. A total of 196 individuals (98 men and 98 women) participated, with an average age of 31 years. Participants were categorized by various socio-demographic characteristics. Descriptive statistics and correlation analysis were applied for data analysis. Research Results and Discussion. The results demonstrated that women are significantly more aware of urogenital system diseases and are more likely to undergo regular medical check-ups: 100% of women reported seeing specialists, with 50% visiting once a year and another 50% every six months. In contrast, only 5.1% of men visit a doctor annually, while 24.5% do so at least once every few years. Among men, 13.8% reported having experienced urogenital system diseases, whereas the prevalence among women was notably higher at 32.7%. The study also revealed a high prevalence of harmful habits, particularly smoking and alcohol consumption, among respondents, which increases the risk of urogenital diseases. Although most participants reside in urban areas, which provides better access to medical services, this does not always translate into better health outcomes. Conclusions. The obtained results indicate the need to increase awareness among men about the importance of regular medical check-ups and preventive measures. It is also crucial to strengthen information campaigns regarding the risks of harmful habits that may lead to serious urogenital diseases. This can help improve public health and reduce the incidence of these conditions.
References
Wagenlehner F. Urogenital infections. World J Urol. 2020 Jan;38(1):1-2. doi: 10.1007/s00345-019-03039-4. PMID: 31788716.
Wong MCS, Fung FDH, Leung C, Cheung WWL, Goggins WB, Ng CF. The global epidemiology of bladder cancer: A joinpoint regression analysis of its incidence and mortality trends and projection. Sci Rep. 2018;8(1):1129. doi: 10.1038/s41598-018-19199-z.
Braver DJ, Modan M, Chêtrit A, Lusky A, Braf Z. Drinking, micturition habits, and urine concentration as potential risk factors in urinary bladder cancer. J Natl Cancer Inst. 1987 Mar;78(3):437-40. PMID: 3469457.
Ilskens K, Wrona KJ, Dockweiler C, Fischer F. An evidence map on serious games in preventing sexually transmitted infections among adolescents: Systematic review about outcome categories investigated in primary studies. JMIR Serious Games. 2022 Feb 2;10(1):e30526. doi: 10.2196/30526. PMID: 35107438; PMCID: PMC8851332.
Rodríguez Cintas M, Márquez S, González-Gallego J. The impact of physical activity on risk and health-related quality of life in bladder cancer. Bladder Cancer. 2021 Aug 31;7(3):355-364. doi: 10.3233/BLC-200406. PMID: 38993609; PMCID: PMC11181820.
Bernstein AP, Bjurlin MA, Sherman SE, Makarov DV, Rogers E, Matulewicz RS. Tobacco screening and treatment during outpatient urology office visits in the United States. J Urol. 2021 Jun;205(6):1755-1761. doi: 10.1097/JU.0000000000001572. Epub 2021 Feb 2. PMID: 33525926.
Metzler I, Bayne D, Chang H, Jalloh M, Sharlip I. Challenges facing the urologist in low- and middle-income countries. World J Urol. 2020 Nov;38(11):2987-2994. doi: 10.1007/s00345-020-03101-6. Epub 2020 Feb 7. PMID: 32034500; PMCID: PMC8186537.
Rafiei S, Kheradkhah G, Kotronoulas G, Doustmehraban M, Shafiei F, Masoumi M, Parnian E, Nosrati Sanjabad E, Ghashghaee A. Quality of life in bladder cancer: Systematic review and meta-analysis. BMJ Support Palliat Care. 2024 Jan 9;13(e3):e707-e714. doi: 10.1136/spcare-2023-004185. PMID: 37400163.
Mancini M, Righetto M, Baggio G. Spotlight on gender-specific disparities in bladder cancer. Urologia. 2020 Aug;87(3):103-114. doi: 10.1177/0391560319887327. Epub 2019 Dec 23. PMID: 31868559.
Denijs FB, van Harten MJ, Meenderink JJL, Leenen RCA, Remmers S, Venderbos LDF, van den Bergh RCN, Beyer K, Roobol MJ. Risk calculators for the detection of prostate cancer: A systematic review. Prostate Cancer Prostatic Dis. 2024 Sep;27(3):544-557. doi: 10.1038/s41391-024-00852-w. Epub 2024 Jun 3. PMID: 38830997.